Split-Face Prospective Study Comparing Botox to Xeomin for the Treatment of Facial Wrinkles

NCT02122536 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Facial Wrinkles

Interventions

DRUG: Xeomin to right side of face in half of the subjects; Xeomin to left side of face in the other half of subjects
DRUG: Botox to right side of face in half of the subjects (randomized); Botox to the left side of the face in the other half of subjects

Sponsor

YMD Eye and Face